Carrier Dan J, Eckers Christine, Wolff Jean-Claude
GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, UK.
J Pharm Biomed Anal. 2008 Aug 5;47(4-5):731-7. doi: 10.1016/j.jpba.2008.03.002. Epub 2008 Mar 14.
An analytical method has been developed for trace analysis (i.e. sub-ppm levels) of a key synthetic impurity, 14W80 ((Z)-2-(2,3-dichlorophenyl)-2-(guanidinylimino)acetonitrile) in lamotrigine (3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine). 14W80 is isobaric with lamotrigine, which gives an extra layer of complexity to its determination and the various problems associated with development of an appropriate methodology are discussed in this work. Ultimately, a liquid chromatography tandem mass spectrometry (LC-MS/MS) method using in-source fragmentation with Atmospheric Pressure Chemical Ionisation (APCI) followed by multiple reaction monitoring (MRM) has been found to provide adequate sensitivity and specificity. A detection limit of 25 ppb mass fraction relative to lamotrigine was achieved for 14W80. The use of solid phase extraction (SPE) enhanced the detection limit to 2 ppb mass fraction relative to lamotrigine.
已开发出一种分析方法,用于痕量分析(即低于百万分之一的水平)拉莫三嗪(3,5 - 二氨基 - 6 - (2,3 - 二氯苯基)-1,2,4 - 三嗪)中的一种关键合成杂质14W80((Z)-2-(2,3 - 二氯苯基)-2-(胍基亚氨基)乙腈)。14W80与拉莫三嗪具有相同的分子量,这给其测定带来了额外的复杂性,本文讨论了与开发合适方法相关的各种问题。最终,发现一种采用大气压化学电离(APCI)源内裂解并随后进行多反应监测(MRM)的液相色谱串联质谱(LC - MS/MS)方法具有足够的灵敏度和特异性。相对于拉莫三嗪,14W80的检测限达到质量分数25 ppb。使用固相萃取(SPE)将相对于拉莫三嗪的检测限提高到质量分数2 ppb。